XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Acquisitions - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 18, 2021
Apr. 07, 2021
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
May 31, 2020
Business Acquisition [Line Items]                  
Cash consideration paid           $ 0 $ 419,404,000    
Common stock, par value (in dollars per share)     $ 0.001     $ 0.001   $ 0.001  
Inivata Limited                  
Business Acquisition [Line Items]                  
Amount outstanding under line of credit   $ 10,300,000              
Variable Interest Entity, Not Primary Beneficiary | Inivata Limited                  
Business Acquisition [Line Items]                  
Investment in minority interest                 $ 25,000,000
Consideration paid to other shareholders   390,000,000              
Marketing Assets                  
Business Acquisition [Line Items]                  
Amortization period of acquired intangible assets (in years)           4 years   4 years  
Trademarks                  
Business Acquisition [Line Items]                  
Amortization period of acquired intangible assets (in years)           15 years   15 years  
Trade Name                  
Business Acquisition [Line Items]                  
Amortization period of acquired intangible assets (in years)           5 years   5 years  
Trapelo Health                  
Business Acquisition [Line Items]                  
Percentage of voting interests acquired (as a percent)     100.00%            
Cash consideration paid     $ 35,591,000            
Payments to acquire business, adjustments     600,000            
Fair value of common stock at Trapelo Acquisition Date     $ 29,174,000            
Shares of common stock issued as consideration (in shares)     597,712            
Stock price per share on closing date (in dollars per share)     $ 48.81            
Amortization period of acquired intangible assets (in years)     9 years 9 months 18 days            
Goodwill, tax deductible amount     $ 0            
Trapelo Health | Developed technology                  
Business Acquisition [Line Items]                  
Intangible assets, useful life (in years)     10 years            
Trapelo Health | Marketing Assets                  
Business Acquisition [Line Items]                  
Intangible assets, useful life (in years)     4 years            
Inivata                  
Business Acquisition [Line Items]                  
Cash consideration paid   398,594,000              
Payments to acquire business, adjustments   $ 8,600,000              
Amortization period of acquired intangible assets (in years)   14 years 10 months 24 days              
Goodwill, tax deductible amount   $ 0              
Line of credit   15,000,000              
Net unrealized loss       $ 5,000,000          
Fair value of previously-held equity interest $ 64,900,000 64,906,000              
Fair value of purchase option $ 74,300,000 74,300,000              
Gain on investment in and loan receivable from non-consolidated affiliate, net               $ 109,300,000  
Increase in goodwill from deferred income tax liabilities   60,994,000              
Gain on investment in and loan receivable from non-consolidated affiliate, net         $ 96,500,000   $ 91,500,000    
Inivata | Clinical Services                  
Business Acquisition [Line Items]                  
Goodwill acquired   238,400,000              
Inivata | Pharma Services                  
Business Acquisition [Line Items]                  
Goodwill acquired   $ 33,000,000.0              
Inivata | Developed technology                  
Business Acquisition [Line Items]                  
Intangible assets, useful life (in years)   15 years              
Inivata | Trademarks                  
Business Acquisition [Line Items]                  
Intangible assets, useful life (in years)   15 years              
Inivata | Trade Name                  
Business Acquisition [Line Items]                  
Intangible assets, useful life (in years)   5 years